Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday, January 24, 2020

 MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2020 ,inter alia, to consider and approve Pursuant to Regulation 29, 33 and other applicable provisions, if any, of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, we have to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, January 24, 2020 at the registered office of the Company at Mumbai, inter-alia to consider and approve the Un-Audited Financial Results of the Company for the quarter ended December 31, 2019.
16-01-2020
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Shareholding for the Period Ended December 31, 2019

 Mangalam Drugs & Organics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here
07-01-2020
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Statement Of Investor Complaints For The Quarter Ended December 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- CS GEETA KARIRADesignation :- Company Secretary and Compliance Officer
06-01-2020
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Closure of Trading Window

 Closure of Trading Window
31-12-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Financial Results Update

 Financial Results Update
29-11-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Compliance Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 Compliance under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith disclosure of Related Party Transactions, in the format specified in the accounting standards for the half year ended September 30, 2019.
14-11-2019
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper Advertisement regarding publication of Un-Audited Financial Results for the quarter and half year ended September 30, 2019.
04-11-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2019 Along With The Limited Review Report.

 In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations), we are enclosing herewith Un-audited Financial Results for the quarter and half year ended September 30, 2019 along with Limited Review Report of the said period in the prescribed form which have been taken on record and approved by the Board of Directors of the Company in its meeting held today i.e. Saturday, November 2, 2019 at Mumbai. Kindly note that meeting of Board of Directors commenced at 2:30 P.M. and concluded at 3:25 P.M. Further please note that the Company has made necessary arrangement to publish the same in newspapers as required under Listing Regulations.
02-11-2019
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Outcome of Board Meeting

 Outcome of the Board Meeting held on November 2, 2019. In terms of Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the listing regulations), we have to inform you that the Board of Directors of the Company, in their meeting held today i.e. Saturday, November 2, 2019 has inter-alia approved the Un-Audited Financial Results for the quarter and half year ended September 30, 2019 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations. The meeting of Board of Directors commenced at 2:30 P.M. and concluded at 3:25 P.M.
02-11-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Clarification

 With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Mangalam Drugs & Organics Ltd has submitted to BSE a copy of Clarification is enclosed.
02-11-2019
Next Page
Close

Let's Open Free Demat Account